AUR: Pharmacy Data Monthly Electronic Upload Specification Tables

Status: Original and derived artifacts are available for this document.

Download: docx | pdf | html

Antimicrobial Use and Resistance (AUR):  Pharmacy Data
Monthly Electronic Upload Specification Tables

These data will be collected in an aggregate monthly electronic file transfer from the facility to NHSN via Clinical Document Architecture (CDA). 
Table 1. CDA File Descriptors
These data elements will be transmitted with each month’s report.
Variable Name
Description of Variable
Facility OID
NHSN Facility ID number
Application OID
Vendor software ID number
SDS validation ID
ID provided by NHSN Team confirming vendor software passed validation 
location
NHSN location code
month
Denominator month
year
Denominator year
Table 2. Aggregate Patient Information
These data elements are aggregated to the location and facility wide inpatient level for each month.
Variable Name
Description of Variable
numDaysPresent
Total number of days present
numTherapyDays
Number of therapy days
numAdmissions
Number of admissions
Table 3. Aggregate Pharmacy Information
These data elements are obtained from the facility’s electronic medication administration record (eMAR) or bar coding medication administration (BCMA) and aggregated to the location and facility wide inpatient level for each month.
Variable Name
Description of Variable
Examples
drugIngredient
Antimicrobial ingredient
(see Table 3a)
routeDrugAdmin
Route of administration
Digestive tract, respiratory tract, intravenous route, intramuscular route
Table 3a. List of Antimicrobials Accepted
This is the list of antimicrobials currently accepted into NHSN as part of the antimicrobial use reporting.
Amantadine
Baloxavir marboxil
Cefpodoxime
Clindamycin
Fluconazole
Metronidazole
Penicillin V
Tedizolid
Amikacin
Caspofungin
Cefprozil
Colistimethate
Fosfomycin
Micafungin
Peramivir
Telavancin
Amikacin Liposomal
Cefaclor
Ceftaroline
Colistin
Gemifloxacin
Minocycline
Piperacillin/ Tazobactam
Tetracycline
Amoxicillin
Cefadroxil
Ceftazidime
Dalbavancin
Gentamicin
Molnupiravir
Pivmecillinam
Tigecycline
Amoxicillin/ Clavulanate
Cefazolin
Ceftazidime/ Avibactam
Daptomycin
Imipenem/ Cilastatin
Moxifloxacin
Plazomicin
Tinidazole
Amphotericin B
Cefdinir
Ceftobiprole medocaril
Delafloxacin
Imipenem/ Cilastatin/ Relebactam 
Nafcillin
Polymyxin B
Tobramycin
Amphotericin B lipid complex
Cefepime
Ceftolozane/ Tazobactam
Dicloxacillin
Isavuconazonium
Nirmatrelvir
Posaconazole
Vancomycin
Amphotericin B liposomal
Cefepime/ Enmetazobactam
Ceftriaxone
Doxycycline
Itraconazole
Nitrofurantoin
Quinupristin/ Dalfopristin
Voriconazole
Ampicillin
Cefiderocol
Cefuroxime
Eravacycline
Lefamulin
Omadacycline
Remdesivir
Zanamivir
Ampicillin/ Sulbactam
Cefixime
Cephalexin
Ertapenem
Levofloxacin 
Oritavancin
Rezafungin

Anidulafungin
Cefotaxime

Erythromycin
Linezolid
Oseltamivir
Rifampin
*Addition pending FDA approval of the drug in Sept 2024
Azithromycin
Cefotetan
Ciprofloxacin
Etzadroxil/ Probenecid*
Meropenem
Oxacillin
Rimantadine

Aztreonam
Cefoxitin
Clarithromycin
Fidaxomicin
Meropenem/ Vaborbactam
Penicillin G
Sulfamethoxazole/ Trimethoprim

Assurance of Confidentiality:  The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).

Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS H21-8, Atlanta, GA 30333, ATTN:  PRA (0920-0666).
CDC 57.124 v9, 13.0